Live webinar on the use of generic, biosimilar and non-biologic complex drugs for multiple sclerosis
Register now!Join this valuable and instructive webinar! Familiarise yourself with the robust European regulatory processes and effective oversight for generic, biosimilar, and follow-on non-biologic complex drugs (NBCDs) of disease modifying […]